CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Planned sale CHAIRMAN & CEO sold 86,270 shares at an average $27.24 ($2,349,981)
- DEFA14A Proxy Proxy Materials
- 4 Planned sale CHAIRMAN & CEO sold 2,349 shares at $27.02 ($63,470)
- 4 Planned sale CHIEF OPERATING OFFICER sold 12,000 shares at $26.41 ($316,920)
- 144 Insider Sale of Securities
- 4 Planned sale CHAIRMAN & CEO sold 2,872 shares at $27.03 ($77,630)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHAIRMAN & CEO sold 8,095 shares at an average $27.04 ($218,866)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 200 shares at $27.00 ($5,400)
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 17,647 shares at $26.69 ($470,998)
- DEFA14A Proxy Proxy Materials
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 10,122 shares at $28.00 ($283,416)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 39 · 778 filings